Northwest Wealth Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Northwest Wealth Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,198	Closed	-$108K	–	490
2019 Q1	$108K	Hold	6,198	–	–	0.08%	153
2018 Q4	$85K	Hold	6,198	–	–	0.07%	161
2018 Q3	$133K	Hold	6,198	–	–	0.1%	128
2018 Q2	$266K	Hold	6,198	–	–	0.2%	92
2018 Q1	$405K	Buy	6,198 +167	+3%	+$11.8K	0.3%	70
2017 Q4	$440K	Hold	6,031	–	–	0.36%	61
2017 Q3	$553K	Sell	6,031 -416	-6%	-$31.9K	0.77%	32
2017 Q2	$426K	Buy	6,447 +193	+3%	+$23.9K	0.39%	54
2017 Q1	$1.36M	Sell	6,254 -133	-2%	-$19K	1.26%	25
2016 Q4	$591K	Buy	+6,387	New	+$720K	0.6%	43

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Northwest Wealth Management's LUMO Position: Q2 2019 in Review

Northwest Wealth Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2019, closing a stake of 6,198 shares — an estimated $108K sold.

Northwest Wealth Management first reported a position in LUMO in Q4 2016 and held it in 10 quarters. The position peaked at $1.36M in Q1 2017. 68 funds tracked by Wall St. Rank hold LUMO as of Q2 2019.

Northwest Wealth Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Northwest Wealth Management sold 6,198 Lumos Pharma, Inc. Common Stock shares in Q2 2019, an estimated $108K.
Northwest Wealth Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2016 and held it in 10 quarters.
Northwest Wealth Management's Lumos Pharma, Inc. Common Stock position peaked at $1.36M in Q1 2017.
68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2019.

Based on Northwest Wealth Management's 13F filing for Q2 2019, filed 23 Jul 2019.